BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 16381702)

  • 1. Neutron shielding calculations in a proton therapy facility based on Monte Carlo simulations and analytical models: criterion for selecting the method of choice.
    Titt U; Newhauser WD
    Radiat Prot Dosimetry; 2005; 115(1-4):144-8. PubMed ID: 16381702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of radiation shielding for the proton therapy facility at the National Cancer Center in Korea.
    Kim JW; Kwon JW; Lee J
    Radiat Prot Dosimetry; 2005; 115(1-4):271-5. PubMed ID: 16381727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional shielding calculations for the IFMIF neutron source using a coupled Monte Carlo/Deterministic computational scheme.
    Chen Y; Fischer U; Simakov SP; Wasastjerna F
    Radiat Prot Dosimetry; 2005; 115(1-4):573-9. PubMed ID: 16381788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary shielding assessment for the 100 MeV proton linac (KOMAC).
    Lee YO; Cho YS; Chang J
    Radiat Prot Dosimetry; 2005; 115(1-4):569-72. PubMed ID: 16381787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of a new IRSN thermal neutron field facility using Monte-Carlo simulations.
    Lacoste V
    Radiat Prot Dosimetry; 2007; 126(1-4):58-63. PubMed ID: 17578877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beam dumps design and local radiation protection at TERA synchrotron.
    Porta A; Campi F; Agosteo S
    Radiat Prot Dosimetry; 2005; 115(1-4):222-6. PubMed ID: 16381716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monte Carlo simulations for the shielding of the future high-intensity accelerator facility FAIR at GSI.
    Radon T; Gutermuth F; Fehrenbacher G
    Radiat Prot Dosimetry; 2005; 115(1-4):212-5. PubMed ID: 16381714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCNPX vs. DORT for SNS shielding design studies.
    Popova II
    Radiat Prot Dosimetry; 2005; 115(1-4):559-63. PubMed ID: 16381785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of deterministic and Monte Carlo methods in shielding design.
    Oliveira AD; Oliveira C
    Radiat Prot Dosimetry; 2005; 115(1-4):254-7. PubMed ID: 16381723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methodology for worker neutron exposure evaluation in the PDCF facility design.
    Scherpelz RI; Traub RJ; Pryor KH
    Radiat Prot Dosimetry; 2004; 110(1-4):725-9. PubMed ID: 15353738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shielding of proton accelerators.
    Agosteo S; Magistris M; Silari M
    Radiat Prot Dosimetry; 2011 Jul; 146(4):414-24. PubMed ID: 21672935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental and Monte Carlo evaluation of the neutron flux of an assembly with two AmBe sources.
    Filho TM; de Lima RB; Yoriyaz H; Hernandes AC
    Radiat Prot Dosimetry; 2005; 115(1-4):412-4. PubMed ID: 16381757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The refined shielding design for the cyclotron room of the Buddhist Tzu Chi General Hospital.
    Sheu RD; Chen CC; Sheu RJ; Kao CH; Jiang SH
    Radiat Prot Dosimetry; 2005; 115(1-4):216-21. PubMed ID: 16381715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical shielding calculations for a proton therapy facility.
    Avery S; Ainsley C; Maughan R; McDonough J
    Radiat Prot Dosimetry; 2008; 131(2):167-79. PubMed ID: 18487617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the neutron beam line shield design for JSNS.
    Kawai M; Saito K; Sanami T; Nakao N; Maekawa F
    Radiat Prot Dosimetry; 2005; 115(1-4):580-6. PubMed ID: 16381789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monte Carlo simulation of the IRSN CANEL/T400 realistic mixed neutron-photon radiation field.
    Lacoste V; Gressier V;
    Radiat Prot Dosimetry; 2004; 110(1-4):123-7. PubMed ID: 15353634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shielding design for the PANDA spectrometer at the Munich high-flux reactor FRM-II.
    Noack K; Pyka NM; Rogov A; Steichele E
    Radiat Prot Dosimetry; 2005; 115(1-4):262-7. PubMed ID: 16381725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multileaf shielding design against neutrons produced by medical linear accelerators.
    Rebello WF; Silva AX; Facure A
    Radiat Prot Dosimetry; 2008; 128(2):227-33. PubMed ID: 17569690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of different dose scoring methods on organ-specific neutron dose calculations in proton therapy.
    Jarlskog CZ; Paganetti H
    Phys Med Biol; 2008 Sep; 53(17):4523-32. PubMed ID: 18677040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo simulations for the design of the treatment rooms and synchrotron access mazes in the CNAO Hadrontherapy facility.
    Porta A; Agosteo S; Campi F
    Radiat Prot Dosimetry; 2005; 113(3):266-74. PubMed ID: 15713741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.